It is estimated that over 300 million people in the world are impacted by rare diseases. In a recent study it was estimated that rare...

Recce Pharmaceuticals (ASX: RCE: FSE: R9Q) is a global leader in the new generation of anti-infective therapies. The company is listed on...

Antisense Therapeutics (ASX: ANP) and (FRA: AWY) are up over 60% in 2 months. 2 major reasons for this: Sarpeta Therapeutics announced...

As the 2020 year of biotech investing draws to a close, mRNA technology stands out as the defining technology of the decade. Never before...

RNA is the target that forms the basis of Ionis's Pharmaceuticals (FRA: ISI) and (NASDAQ: IONS) novel drug discovery platform, The...

An exciting and innovative Australian biotech - Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) has now listed on the Frankfurt...